UY37198A - Vacuna universal para enfermedades virales - Google Patents
Vacuna universal para enfermedades viralesInfo
- Publication number
- UY37198A UY37198A UY0001037198A UY37198A UY37198A UY 37198 A UY37198 A UY 37198A UY 0001037198 A UY0001037198 A UY 0001037198A UY 37198 A UY37198 A UY 37198A UY 37198 A UY37198 A UY 37198A
- Authority
- UY
- Uruguay
- Prior art keywords
- polypeptides
- proteins
- peptides
- viral
- viral peptides
- Prior art date
Links
- 230000003612 virological effect Effects 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 10
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 10
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 241000700605 Viruses Species 0.000 abstract 3
- 239000002671 adjuvant Substances 0.000 abstract 3
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a una combinación farmacéutica para inducir protección cruzada contra múltiples cepas o serotipos de un virus. Esta vacuna universal comprende un partículas virales inactivadas con uno o más de los siguientes componentes: polinucleótidos que codifican péptidos, polipéptidos o proteínas virales en diferentes tipos de plásmidos; péptidos, polipéptidos y proteínas virales; péptidos y polipéptidos virales sintéticos; péptidos, polipéptidos y proteínas virales recombinantes; VLPs; VLPs derivadas de otros virus; proteínas usadas como carrier o como adyuvante molecular fusionadas a péptidos, polipéptidos y/o proteínas derivadas de virus; adyuvantes; emulsionantes, adyuvantes moleculares y sistemas carrier.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662320852P | 2016-04-11 | 2016-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY37198A true UY37198A (es) | 2017-11-30 |
Family
ID=60041433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001037198A UY37198A (es) | 2016-04-11 | 2017-04-07 | Vacuna universal para enfermedades virales |
Country Status (9)
Country | Link |
---|---|
US (2) | US10940196B2 (es) |
EP (1) | EP3443097A4 (es) |
KR (1) | KR20180132742A (es) |
CN (1) | CN109196104B (es) |
AR (1) | AR108014A1 (es) |
BR (1) | BR112018070634A2 (es) |
TW (1) | TWI763662B (es) |
UY (1) | UY37198A (es) |
WO (1) | WO2017178945A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3909970A1 (en) * | 2020-05-14 | 2021-11-17 | Consejo Superior De Investigaciones Científicas | Peptide vaccines for the prevention of foot-and-mouth disease |
CN111744000B (zh) * | 2020-07-14 | 2021-03-23 | 中国农业科学院兰州兽医研究所 | 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用 |
CN111978380A (zh) * | 2020-09-02 | 2020-11-24 | 天康生物股份有限公司 | 野生型气肿疽梭菌细胞毒素a及其制备方法、应用和疫苗 |
CN114748617B (zh) * | 2022-03-24 | 2024-04-16 | 华南农业大学 | 一种大口黑鲈虹彩病毒的亚单位疫苗及其制备方法和应用 |
CN114874338B (zh) * | 2022-05-18 | 2024-04-12 | 华中农业大学 | 一种口蹄疫病毒纳米颗粒及其制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1245217C (zh) * | 2001-02-15 | 2006-03-15 | 雷吉斯特印度科学院 | 一种包含dna疫苗和灭活狂犬病毒的疫苗制剂 |
CN1408434A (zh) * | 2002-09-16 | 2003-04-09 | 复旦大学 | 抗家畜口蹄疫的多肽和dna联合疫苗及其制备方法 |
AR044603A1 (es) * | 2004-06-03 | 2005-09-21 | Consejo Nac Invest Cient Tec | Proteinas quimericas aisladas de lumazina sintetasa modificada para la presentacion multiple de moleculas y sus aplicaciones |
CN106987595B (zh) * | 2009-11-02 | 2021-07-06 | 宾夕法尼亚大学托管会 | 口蹄疫病毒病毒(fmdv)共有蛋白质、其编码序列及由其制备的疫苗 |
CN101948811B (zh) * | 2010-08-18 | 2013-01-09 | 中国农业科学院兰州兽医研究所 | 用反向遗传操作拓展口蹄疫疫苗株抗原谱及疫苗制备方法 |
CN102168088B (zh) * | 2010-12-23 | 2012-12-26 | 中国农业科学院兰州兽医研究所 | T细胞免疫原基因ti及其在口蹄疫蛋白亚单位疫苗和灭活疫苗中的应用 |
MX2015011931A (es) | 2013-03-15 | 2016-04-07 | Novavax Inc | Expresion mejorada de proteinas de picornavirus. |
MX368441B (es) * | 2013-05-27 | 2019-10-02 | Inmunova S A | Quimeras de lumazina sintasa de brucella y la subunidad beta de toxinas ab5. |
CN105056227B (zh) | 2015-07-21 | 2017-12-29 | 复旦大学 | 一种抗口蹄疫病毒的类病毒粒子vlp疫苗及其制备方法 |
-
2017
- 2017-04-07 UY UY0001037198A patent/UY37198A/es not_active Application Discontinuation
- 2017-04-07 KR KR1020187031047A patent/KR20180132742A/ko not_active Application Discontinuation
- 2017-04-07 EP EP17782018.0A patent/EP3443097A4/en not_active Withdrawn
- 2017-04-07 BR BR112018070634A patent/BR112018070634A2/pt not_active Application Discontinuation
- 2017-04-07 CN CN201780022979.4A patent/CN109196104B/zh active Active
- 2017-04-07 WO PCT/IB2017/052030 patent/WO2017178945A1/en active Application Filing
- 2017-04-07 US US16/092,660 patent/US10940196B2/en active Active
- 2017-04-10 TW TW106111892A patent/TWI763662B/zh active
- 2017-04-10 AR ARP170100911A patent/AR108014A1/es unknown
-
2021
- 2021-03-08 US US17/194,460 patent/US20210187096A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US10940196B2 (en) | 2021-03-09 |
TW201740973A (zh) | 2017-12-01 |
US20210187096A1 (en) | 2021-06-24 |
AR108014A1 (es) | 2018-07-11 |
CN109196104A (zh) | 2019-01-11 |
EP3443097A1 (en) | 2019-02-20 |
KR20180132742A (ko) | 2018-12-12 |
CN109196104B (zh) | 2023-01-31 |
US20190142926A1 (en) | 2019-05-16 |
BR112018070634A2 (pt) | 2019-02-05 |
EP3443097A4 (en) | 2020-04-22 |
TWI763662B (zh) | 2022-05-11 |
WO2017178945A1 (en) | 2017-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37198A (es) | Vacuna universal para enfermedades virales | |
CY1124254T1 (el) | Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας | |
MX2021006931A (es) | Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos. | |
CL2018000740A1 (es) | Vectores del factor viii del virus adeno-asociado, partículas víricas asociadas y formulaciones terapéuticas que los comprenden | |
CO2018007203A2 (es) | Focalización de péptidos para dirigir virus adenoasociados (aavs) | |
BR112016007868A2 (pt) | vacinas contra o vírus de epstein-barr | |
BR112018075032A2 (pt) | proteínas de hemaglutinina do vírus influenza e seus uso | |
CU24580B1 (es) | Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas | |
MY191322A (en) | Recombinant vectors expressing antigens of avian influenza virus and uses thereof | |
AR101814A1 (es) | Partícula de tipo virus flavivirus | |
PH12020500569A1 (en) | Influenza virus vaccines and uses thereof | |
NZ739260A (en) | Inactivated canine influenza vaccines and methods of making and uses thereof | |
EA201890042A1 (ru) | Вакцина против вируса ящура (вя) на основе рекомбинантного модифицированного вируса осповакцины анкара (mva) | |
MY179251A (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
PE20170429A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
PH12018502436A1 (en) | Multivalent vaccines major swine viral diseases | |
PH12017500419A1 (en) | Recoded arbovirus and vaccines | |
AR095425A1 (es) | Vacuna, uso y procedimiento para prevenir una infección por picornavirus | |
BR112018015912A2 (pt) | vírus da vacina da síndrome respiratória e reprodutiva porcina | |
CL2019000405A1 (es) | Vacunas virales. | |
EP3599247A3 (en) | Recombinant hemagglutinin protein of influenza virus and vaccine containing the same | |
MX2019007924A (es) | Vacunas contra la influenza. | |
BR112017024786A2 (pt) | virus oncolíticos recombinantes e usos dos mesmos | |
MX360137B (es) | Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento. | |
BR112019008584A2 (pt) | vacinas de mosaico para vírus de doença de pé-e-boca de sorotipo a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20231110 |